Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Greenlane Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Keel Infrastructure Schedules First Quarter 2026 Conference Call on May 11, 2026
-
KUSTOM ENTERTAINMENT TO HIGHLIGHT STRATEGIC PROGRESS AT THE 16th ANNUAL LD MICRO INVITATIONAL
-
CADV Ventures S.A. to Combine with Miluna Acquisition Corp to Become a Publicly Listed Company
-
Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
-
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
-
NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer
-
One Bullion Reports High Concentration of Gold During Artisanal Sampling Program at Vumba Project Which Yielded a 679 g/t Gold Sample
-
NIMA’s Next-Gen Portable Gluten Sensor Wins Gold Stevie® Award for Achievement in Product Innovation
-
BriaCell Announces Six Clinical Data Presentations at ASCO 2026
-
CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transpla
-
HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors
-
Scorpio Tankers Inc. Announces New Credit Facility
-
Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy
-
Suja Life Announces Launch of Initial Public Offering
-
Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
-
Allot to Release First Quarter 2026 Results and Host Conference Call on May 12, 2026
-
HBT Financial, Inc. Announces First Quarter 2026 Financial Results
-
CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®
-
CareMetx Acquires U.S.-based Patient Services and Free Goods Pharmacy Operations from Cencora, Significantly Expanding Its Patient Access Platform
-
Black Diamond Group Announces Expansion Of Asset-Based Credit Facility
-
Nearly 3 in 10 Canadians Have Yet to File Their Taxes Despite Being Just Days Away from The Filing Deadline with More Than 1 in 10 Who Say They’ll Miss the Deadline, Reveals New H&R Block Study
-
Secura Bio Announces Journal of Clinical Oncology Publication of Final Results of Duvelisib PRIMO Phase 2 Trial in Relapsed/Refractory Peripheral T-cell Lymphoma
-
Yukon Metals Options Copper-Gold Project from Renowned Yukon Prospector Ryan Burke, Solidifying Position in Emergent Birch District
-
Canadian Premium Sand Inc. Announces Option Grants
-
Surge Copper Announces Closing of Final Tranche of $20 Million Private Placement
-
Abcourt intersects 1.7 g/t gold over 12 metres including 15.2 g/t gold over 1 metre in drilling on its Flordin property, in the eastern extension of the Cartwright stripping
-
Astec Announces Quarterly Dividend
-
Lakeland Financial Reports Record First Quarter Performance; Loan Growth of 5% and Revenue Growth of 9% Contribute to 32% Increase in Net Income to $26.5 Million
-
Youxin Technology Announces to Strategically Acquire YATOP Worth $10.8 Million Shares to Expand Global TikTok Ecosystem and Digital Commerce Capabilities
-
Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group
-
Sagimet Biosciences Provides Strategic and Corporate Updates
-
Verizon’s Transformation Actions Deliver Growth & Profitability in 1Q26; Company Raises Adjusted EPS Guidance
-
Chicago’s Water Tower Place Announces Major Redevelopment to Modernize Iconic Mag Mile Destination
-
Palomino Laboratories Inc. Closes $15 Million at $4/share
-
Fenix Outdoor International to acquire outstanding minority in Devold
-
Q1 report Fenix Outdoor International AG
-
Aeluma Appoints Willy Rachmady Vice President of Strategic Partnerships and Ecosystem
-
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
-
Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities
-
Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026
-
Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing
-
Martin Marietta Appoints Christopher W. Samborski Chief Operating Officer
-
Recognized for Best Use of Tech in HR, Vetty Wins Bronze Stevie® in 2026 American Business Awards®
-
Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026
-
U.S. Energy Corp. Signs Five-Year Helium Offtake Agreement with Investment-Grade Global Leader in Industrial Gases
-
Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences
-
Verizon’s Transformation Actions Deliver Growth & Profitability in 1Q26; Company Raises Adjusted EPS Guidance
-
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
